Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 1.1% and the Health Care Select Sector SPDR Fund (XLV) climbing 1.3%.
The iShares Biotechnology ETF (IBB) added 0.7%.
In corporate news, Johnson & Johnson (JNJ) agreed to buy Intra-Cellular Therapies (ITCI) for $14.6 billion in cash to boost its neuroscience portfolio. Intra-Cellular shares jumped 34%, and Johnson & Johnson rose 1.4%.
Moderna (MRNA) shares fell 20% after the company cut its full-year revenue outlook, while the drugmaker aims to reduce cash costs by $1 billion in 2025.
Eli Lilly (LLY) agreed to acquire an experimental treatment for breast cancer and other advanced solid tumors from Scorpion Therapeutics for up to $2.5 billion. Eli Lilly shares rose 0.2%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.